* Says collaboration with Stanford University School Of
Medicine for evaluation of Redhill’s Phase II stage drug, YELIVA
The post BRIEF-Redhill Biopharma announces collaboration with Stanford University for YELIVA appeared first on NASDAQ.
BRIEF-Redhill Biopharma announces collaboration with Stanford University for YELIVA
